Market Snapshot: Dow rises to start Oct and Q4 as Merck reports success in COVID antiviral drug trial, but Nasdaq weighed by tech weakness

U.S. stock benchmarks rise Friday morning to kick off the start of the final quarter of the year, following heavy selling that closed a bruising September for investors.

U.S. stock benchmarks rise Friday morning to kick off the start of the final quarter of the year, following heavy selling that closed a bruising September for investors.